Universidad Tecnológica de Pereira Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2008
NCT00692757
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital Universitario San Jorge, Pereira. | Universidad Tecnológica de Pereira

Active Ingredients

Drugs in Phase 3 Trials (2)

emtricitabine (emtriva) (1 trial)

tenofovir (viread) (1 trial)

Drugs in Phase 2 Trials (2)

hypochlorous acid (1 trial)

povidone-iodine (betadine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Coronavirus Infections (Phase 3)

Infections (Phase 2)

Severe Acute Respiratory Syndrome (Phase 3)

Surgical Wound Infection (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4